CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59.

Source:http://linkedlifedata.com/resource/pubmed/id/11719378

Blood 2001 Dec 1 98 12 3383-9

Download in:

View as

Triples

General Info

PMID
11719378